An HCP survey-based active surveillance study to assess the safety of fixed dose combination of Levonorgestrel-Ethinyloestradiol (brand name Ovral-L) in the management of primary dysmenorrhea, endometriosis, and abnormal uterine bleeding among Indian females - Protocol# B6261001

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Not applicable